NCT01014065
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +26 more
- Locations
-
- University of Alberta/ Cross Cancer Institute Edmonton, Alberta, Canada
Clinical trial condition
Explore clinical trials studying Cardiotoxicity. Study availability and eligibility vary by location and protocol.
NCT01014065
NCT02086695
NCT01246778
NCT01665300